Literature DB >> 7989589

The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma.

E Steyrer1, S Durovic, S Frank, W Giessauf, A Burger, H Dieplinger, R Zechner, G M Kostner.   

Abstract

The composition of lipoproteins in the plasma of patients with LCAT deficiency (LCAT-D) is grossly altered due to the lack of cholesteryl esters which form the core of normal lipoproteins. When plasma from LCAT-D patients and their relatives was examined we found that nine heterozygotes had plasma Lp(a) levels of 2-13 mg/dl whereas none of 11 affected homozygous individuals from different families contained detectable amounts of Lp(a) in their plasma. Therefore, the binding of apo(a) to LDL density particles was studied in vitro using LDL density fractions prepared from patients, and recombinant apo(a) [r-apo(a)], which was expressed and secreted by transfected COS-7 cells. The LDL from heterozygotes were chemically indistinguishable from normal LDL and homogeneous with regard to morphology, whereas the crude LDL floating fraction from homozygotes consisted of a heterogeneous mixture of large vesicles, and small spheres resembling normal LDL. The LDL density fraction from the LCAT-D patient lacked almost completely cholesteryl esters. Incubation of LCAT-D plasma with active LCAT caused a substantial augmentation of the original subfraction which morphologically resembled normal LDL. Using r-apo(a) and normal LDL or LDL of heterozygous individuals, apoB:r-apo(a) complexes were formed when incubated at 37 degrees C in vitro for 20 h. In contrast, the total LDL floating fraction from a homozygous LCAT-D patient failed to form apoB:r-apo(a) complexes. After treatment with active LCAT, a significant apoB:r-apo(a) association was observed with LCAT-D LDL-density particles. Our data emphasize the importance of the integrity of LDL structure and composition for the formation of Lp(a). In addition, we demonstrate that the absence of LCAT activity has a fundamental impact on the regulation of plasma Lp(a) levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989589      PMCID: PMC330062          DOI: 10.1172/JCI117598

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro.

Authors:  K R Norum; J A Glomset; A V Nichols; T Forte; J J Albers; W C King; C D Mitchell; K R Applegate; E L Gong; V Cabana
Journal:  Scand J Clin Lab Invest Suppl       Date:  1975

2.  Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a).

Authors:  V W Armstrong; A K Walli; D Seidel
Journal:  J Lipid Res       Date:  1985-11       Impact factor: 5.922

3.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

Authors:  G Utermann; H J Menzel; H G Kraft; H C Duba; H G Kemmler; C Seitz
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Familial lecithin:cholesterol acyltransferase deficiency--a clinical survey.

Authors:  E Gjone
Journal:  Scand J Clin Lab Invest Suppl       Date:  1974

5.  Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation.

Authors:  G M Kostner; J R Patsch; S Sailer; H Braunsteiner; A Holasek
Journal:  Eur J Biochem       Date:  1974-06-15

Review 6.  Plasma lipid transfer proteins.

Authors:  A R Tall
Journal:  J Lipid Res       Date:  1986-04       Impact factor: 5.922

Review 7.  Lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes.

Authors:  J Frohlich; R McLeod
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

8.  Human plasma lipoprotein [a]. Structural properties.

Authors:  J W Gaubatz; C Heideman; A M Gotto; J D Morrisett; G H Dahlen
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

9.  Abnormalities in lipoproteins of d < 1.006 g/ml in familial lecithin:cholesterol acyltransferase deficiency.

Authors:  J A Glomset; K Applegate; T Forte; W C King; C D Mitchell; K R Norum; E Gjone
Journal:  J Lipid Res       Date:  1980-11       Impact factor: 5.922

10.  Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.

Authors:  M J Callow; L J Stoltzfus; R M Lawn; E M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more
  14 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

Review 2.  Lipoprotein (a): a historical appraisal.

Authors:  Karam M Kostner; Gert M Kostner
Journal:  J Lipid Res       Date:  2016-11-07       Impact factor: 5.922

3.  Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon.

Authors:  Benjamin J Visser; Sophia G de Vries; Rieke Vingerling; Martin Gritter; Danielle Kroon; Lídia Ciudad Aguilar; Rik B J Kraan; Rosanne W Wieten; François Danion; Barbara Sjouke; Akim A Adegnika; Selidji T Agnandji; Peter G Kremsner; Thomas Hänscheid; Petra F Mens; Michèle van Vugt; Martin P Grobusch
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

4.  Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.

Authors:  Adriaan G Holleboom; Georgios Daniil; Xiaoming Fu; Renliang Zhang; G Kees Hovingh; Alinda W Schimmel; John J P Kastelein; Erik S G Stroes; Joseph L Witztum; Barbara A Hutten; Sotirios Tsimikas; Stanley L Hazen; Angeliki Chroni; Jan Albert Kuivenhoven
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-27       Impact factor: 8.311

5.  Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.

Authors:  Jin Li; Leslie A Lange; Jeremy Sabourin; Qing Duan; William Valdar; Monte S Willis; Yun Li; James G Wilson; Ethan M Lange
Journal:  J Hum Genet       Date:  2015-09-17       Impact factor: 3.172

Review 6.  Clinical Application of Genetic Testing in Heart Failure.

Authors:  Ana Morales; Ray Hershberger
Journal:  Curr Heart Fail Rep       Date:  2017-12

Review 7.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

8.  Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a).

Authors:  Yan-Ting Wang; Anne von Zychlinski; Sally P A McCormick
Journal:  J Lipid Res       Date:  2008-12-19       Impact factor: 5.922

9.  A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.

Authors:  Xianghong Zhu; Andrew M Herzenberg; Mohammad Eskandarian; Graham F Maguire; James W Scholey; Philip W Connelly; Dominic S Ng
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

10.  A single G to A nucleotide transition in exon IV of the lecithin: cholesterol acyltransferase (LCAT) gene results in an Arg140 to His substitution and causes LCAT-deficiency.

Authors:  E Steyrer; S Haubenwallner; G Hörl; W Giessauf; G M Kostner; R Zechner
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.